Operating income Yuhan 2015-2023
In 2023, South Korean pharmaceutical company Yuhan's consolidated operating income amounted to around 57 billion South Korean won. This represents an increase of around 20 billion won to the previous year.
In 2023, South Korean pharmaceutical company Yuhan's consolidated operating income amounted to around 57 billion South Korean won. This represents an increase of around 20 billion won to the previous year.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Overview
International trade
Pharmaceutical sales
Pharmaceutical expenditure of the National Health System
Research and development
Company rankings
Further related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.